14.11.2012 Aufrufe

Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

MEHR ANZEIGEN
WENIGER ANZEIGEN

Erfolgreiche ePaper selbst erstellen

Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.

104 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />

Cost of Sales<br />

Cost of sales are the acquisition and manufacturing costs incurred in sales generated in the reporting<br />

period. They include directly linked personnel and material costs as well as attributable overhead and<br />

depreciation.<br />

Realization of expenses and earnings<br />

Sales revenues and other operating income are realized after a definite contract is concluded, the delivery<br />

or service was provided, the selling price is fixed or fixable and receiving of the economic benefit is<br />

sufficiently probable. Cash discounts, premiums and discounts reduce the earnings.<br />

Operating expenses are affecting net income at the time of their realization. Interest earnings as well as<br />

interest expenses will be included in accordance with the accruals concept.<br />

Government subsidies<br />

Subsidies received from governments are only recognized, according to IAS 20 “Accounting of government<br />

grants and disclosure of government assistance,” if there is reasonable certainty of the company’s<br />

compliance with the related conditions and the subsidies will be granted.<br />

Government subsidies are scheduled and recognized as income for the respective periods related to the<br />

affected expenses that are to be offset by these subsidies. If subsidies are granted for expenses or losses<br />

in the past or for the purpose of immediate financial support without any future costs, they are recognized<br />

as gains for the respective period of the accrued liability.<br />

The company has received public sector funds from various sources for investment in technical equipment<br />

as well as research and development.<br />

Government subsidies for assets are recognized as abatement of the purchase price. Subsidies not relating<br />

to assets are recognized in the income statement as other operating income. This refers to subsidies<br />

for research and development projects.<br />

The subsidies for research projects recognized in the income statement total KEUR 1,254 (preceding<br />

year: KEUR 1,162).<br />

The investment grants and subsidies are partially still subject to review. However, the company has not<br />

identified any risks with regard to repayment requirements.<br />

Distribution costs<br />

Advertising expenses, marketing costs and other distribution costs are immediately recognized.<br />

Research and development costs<br />

Expenditures for research and development will be included directly to the related income statement as<br />

far as they do not meet the requirements for capitalization pursuant to IAS 38.

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!